Clonidine abolishes the adverse effects on apoptosis and behaviour after neonatal ketamine exposure in mice

作者: E. PONTÉN , H. VIBERG , T. GORDH , P. ERIKSSON , A. FREDRIKSSON

DOI: 10.1111/J.1399-6576.2012.02722.X

关键词:

摘要: Background: An increasing amount of both experimental and epidemiological data indicates that neonatal anaesthesia causes disruption normal brain development in rodents primates, as manifested by acute increased apoptosis longlasting altered behaviour learning. It is necessary to seek strategies avoid the possible adverse effects after anaesthesia. Our purpose show behavioural alterations ketamine exposure during this period may be prevented clonidine, a compound already used paediatric anaesthetists for sedation. Methods: To investigate protective properties clonidine pre-treatment, five groups 10-day-old mice were injected with either 50 mg/kg, 40 mg/kg 30 min 10 or saline (control). Apoptosis was measured 24 h treatment using Flouro-Jade staining. Spontaneous activity novel environment tested at an age 55 days. Results: Pre-treatment but not before abolished ketamine-induced changes observed young adult mice. The exposed alone showed no differences from saline-treated (control) Conclusion: administration eliminated mouse model, suggesting strategy protection. Alone, did cause any these tests.

参考文章(63)
J Altman, Xin Zhang, S. A Bayer, R. J Russo, Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat Neurotoxicology. ,vol. 14, pp. 83- 144 ,(1993)
Keira P. Mason, Jerrold Lerman, Dexmedetomidine in Children Anesthesia & Analgesia. ,vol. 113, pp. 1129- 1142 ,(2011) , 10.1213/ANE.0B013E31822B8629
Eriksson P, Developmental neurotoxicity of environmental agents in the neonate. Neurotoxicology. ,vol. 18, pp. 719- 726 ,(1997)
Andrew J. Davidson, Anesthesia and neurotoxicity to the developing brain: the clinical relevance. Pediatric Anesthesia. ,vol. 21, pp. 716- 721 ,(2011) , 10.1111/J.1460-9592.2010.03506.X
A Bruzzone, C Pérez Piñero, L F Castillo, M G Sarappa, P Rojas, C Lanari, I A Lüthy, α2‐Adrenoceptor action on cell proliferation and mammary tumour growth in mice British Journal of Pharmacology. ,vol. 155, pp. 494- 504 ,(2009) , 10.1038/BJP.2008.278
Chainllie Young, Vesna Jevtovic-Todorovic, Yue-Qin Qin, Tatyana Tenkova, Haihui Wang, Joann Labruyere, John W Olney, Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. British Journal of Pharmacology. ,vol. 146, pp. 189- 197 ,(2005) , 10.1038/SJ.BJP.0706301
R. D. SANDERS, P. SUN, S. PATEL, M. LI, M. MAZE, D. MA, Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiologica Scandinavica. ,vol. 54, pp. 710- 716 ,(2009) , 10.1111/J.1399-6576.2009.02177.X
U. H. Winzer-Serhan, F. M. Leslie, Expression of alpha2A adrenoceptors during rat neocortical development. Journal of Neurobiology. ,vol. 38, pp. 259- 269 ,(1999) , 10.1002/(SICI)1097-4695(19990205)38:2<259::AID-NEU8>3.0.CO;2-U
Souhayl Dahmani, Andrea Paris, Virginie Jannier, Lutz Hein, Danielle Rouelle, Jens Scholz, Pierre Gressens, Jean Mantz, Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology. ,vol. 108, pp. 457- 466 ,(2008) , 10.1097/ALN.0B013E318164CA81
Marc Brede, Stefan Braeuninger, Friederike Langhauser, Lutz Hein, Norbert Roewer, Guido Stoll, Christoph Kleinschnitz, α2-Adrenoceptors do not Mediate Neuroprotection in Acute Ischemic Stroke in Mice Journal of Cerebral Blood Flow and Metabolism. ,vol. 31, ,(2011) , 10.1038/JCBFM.2011.110